Sirolimus Eluting Coronary Stent System 3 Years Shelf life

Sirolimus Eluting Coronary Stent System The Eurolimus is a drug eluting stent delivery system. The stent is coated with the active pharmaceutical ingredient sirolimus (1.4 pg/mm2) within a biodegradable PLGA matrix. Sirolimus • Sirolimus is a drug with an antiproliferative and antiinflammatory effect which is used to coat coronary stents. • Sirolimus is the generic name of the natural product rapamycin, produced by strains of the bacterium Streptomyces hygroscopicus. • Sirolimus inactivates the TOR protein and thus blocks transition from the G1 phase to the S phase in the cell cycle and therewith...

Sirolimus Eluting Coronary Stent System The Coating makes the difference The alliance of a fully biodegradable polymer, together with sirolimus‘s efficiency to prevent restenosis, assures homogeneous drug distribution and uniform release kinetics. Such combination is expected to demonstrate long term efficacy as well as extremely low rates of late stent thrombosis. Polymer Degradation / Drug Release % Sirolimus release Homogeneous Drug Distribution The Eurolimus coating allows a simultaneous polymer resorption and drug release within 3–4 months, to match the procedure-triggered biological response....

Sirolimus Eluting Coronary Stent System Compliance Chart Pressure (MPa / bar/atm) Rated Burst Pressure | - Do not exceed Product Ordering Information Balloon Diameter (mm) EULI 3.00-10 EULI 3.00-13 EULI 3.00-16 EULI 3.00-18 EULI 3.00-23 EULI 3.00-28 EULI 3.00-33 EULI 3.00-38 EULI 3.00-43 EULI 3.00-48 special request EULI 2.25-10 EULI 2.25-13 EULI 2.25-16 EULI 2.25-18 EULI 2.25-23 EULI 2.25-28 EULI 2.25-33 EULI 2.25-38 EULI 2.25-43 EULI 2.25-48 EULI 2.50-10 EULI 2.50-13 EULI 2.50-16 EULI 2.50-18 EULI 2.50-23 EULI 2.50-28 EULI 2.50-33 EULI 2.50-38 EULI 2.50-43 EULI 2.50-48 EULI 2.75-10 EULI 2.75-13...